4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-002279
Chief Scientific Officer sold 87,779 shares at an average $18.57 ($1,629,985)
- Chief Scientific Officer acquired 68,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-01-03 | Option exercise 10b5-1 | +45,326 | $1.03 | $46,686 | 221,911 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-01-03 | Sale 10b5-1 | −15,382 | $18.34 | $282,106 | 206,529 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-01-03 | Sale 10b5-1 | −24,583 | $19.05 | $468,306 | 181,946 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-01-03 | Sale 10b5-1 | −5,361 | $20.50 | $109,901 | 176,585 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-01-04 | Option exercise 10b5-1 | +22,674 | $1.03 | $23,354 | 199,259 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-01-04 | Sale 10b5-1 | −42,453 | $18.13 | $769,673 | 156,806 | D |
| Derivatives | |||||||
| Beskrovnaya Oxana Chief Scientific Officer | 2024-01-03 | Option exercise · Stock option (right to buy) 10b5-1 | −45,326 | 53,100 | D | ||
| Beskrovnaya Oxana Chief Scientific Officer | 2023-01-04 | Option exercise · Stock option (right to buy) 10b5-1 | −22,674 | 30,426 | D | ||
| Open-market sales · 87,779 sh · avg $18.57 · $1,629,985 | |||||||
Loading xslF345X05/ownership.xml…